Deep Birjani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Deep Birjani has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Maryam Ahmed
Dow University of Health Sciences, Karachi, Pakistan, Pakistan
2 shared publications - Muhammad Sameer Khan
Dow University of Health Sciences, Karachi, Pakistan, Pakistan
2 shared publications - Abu Huraira Bin Gulzar
Department of Medicine Services Institute of Medical Sciences Lahore Pakistan
1 shared publication - Areeba Shafiq
Department of Medicine and Surgery, Dow University of Health Sciences, Karachi, Pakistan
1 shared publication - Asad Ali Ahmed Cheema
Department of Medicine, International School of Medicine, International University of Kyrgyzstan, Bishkek, Kyrgyzstan
1 shared publication - Ayesha Ahmed
Dow University of Health Sciences, Karachi, Pakistan, Pakistan
1 shared publication
Latest Publications
- Open Access
- 8 September 2026
- Published by MDPI AG in Preprints.org
The Burden of Pneumonia- and Malnutrition-Associated Mortality Among U.S. Adults Aged 65 Years and Older, 1999–2020
Pneumonia and malnutrition are major contributors to mortality among older adults, yet their combined population-level burden remains poorly defined. We examined national trends and sociodemographic disparities in pneumonia and malnutrition-associated mortality among adults aged 65 years and older in the United States by analyzing data from the CDC WONDER Multiple Cause of Death database from 1999 to 2020. Age-adjusted mortality rates (AAMR) per 100,000 population were calculated, and temporal trends were assessed using Joinpoint regression. Between 1999 and 2020, 81,753 deaths involving both conditions occurred. The overall AAMR declined from 13.82 to 11.90 per 100,000, though a sharp increase occurred from 2017 to 2020. Mortality rates were higher among males, adults aged 85 and older, American Indian/Alaska Native and Black individuals, nonmetropolitan populations, and residents in the South, with Texas exhibiting the highest state-level rate. Pneumonia and malnutrition-associated mortality among older U.S. adults declined over much of the study period but increased substantially in recent years. Persistent demographic and geographic disparities suggest that vulnerable older adults remain at elevated risk, highlighting the need for integrated pneumonia prevention, nutritional screening, and targeted early interventions.
- 8 September 2026
- Published by MDPI AG in Preprints.org
Open AccessThe Burden of Pneumonia- and Malnutrition-Associated Mortality Among U.S. Adults Aged 65 Years and Older, 1999–2020
Pneumonia and malnutrition are major contributors to mortality among older adults, yet their combined population-level burden remains poorly defined. We examined national trends and sociodemographic disparities in pneumonia and malnutrition-associated mortality among adults aged 65 years and older in the United States by analyzing data from the CDC WONDER Multiple Cause of Death database from 1999 to 2020. Age-adjusted mortality rates (AAMR) per 100,000 population were calculated, and temporal trends were assessed using Joinpoint regression. Between 1999 and 2020, 81,753 deaths involving both conditions occurred. The overall AAMR declined from 13.82 to 11.90 per 100,000, though a sharp increase occurred from 2017 to 2020. Mortality rates were higher among males, adults aged 85 and older, American Indian/Alaska Native and Black individuals, nonmetropolitan populations, and residents in the South, with Texas exhibiting the highest state-level rate. Pneumonia and malnutrition-associated mortality among older U.S. adults declined over much of the study period but increased substantially in recent years. Persistent demographic and geographic disparities suggest that vulnerable older adults remain at elevated risk, highlighting the need for integrated pneumonia prevention, nutritional screening, and targeted early interventions.
- Open Access
- 20 August 2026
- Published by Wiley in Journal of Arrhythmia
- Vol. 42 (4) , e70446
Clinical Outcomes of Pulsed Field Vs. Thermal Ablation for Paroxysmal Atrial Fibrillation: Systematic Review and Meta‐Analysis of Randomized Evidence
Aims: Pulsed field ablation (PFA) is a non‐thermal alternative to conventional thermal ablation for paroxysmal atrial fibrillation (AF). We conducted an updated systematic review and meta‐analysis of randomized evidence comparing efficacy, safety, and procedural outcomes. Methods: PubMed/MEDLINE and the Cochrane Central Register of Controlled Trials were searched from inception through March 2026 for randomized controlled trials (RCTs) comparing PFA with thermal ablation in adults undergoing first catheter ablation for paroxysmal AF. Risk ratios (RRs) or mean differences (MDs) with 95% confidence intervals (CIs) were pooled using random‐effects models. Results: Four RCTs enrolling 1 393 patients were included. PFA showed no statistically detectable difference in 12‐month treatment success (RR, 1.04; 95% CI, 0.97 to 1.12; I 2 = 7%), recurrent atrial arrhythmias (RR, 1.00; 95% CI, 0.77 to 1.29; I 2 = 42%), or composite serious adverse events (RR, 0.71; 95% CI, 0.32 to 1.57; I 2 = 7%). PFA shortened procedure time (MD, −22.42 min; 95% CI, −33.44 to −11.39; I 2 = 91%) and LA dwell time (MD, −25.73 min; 95% CI, −34.66 to −16.79; I 2 = 92%), but increased fluoroscopy time (MD, 7.34 min; 95% CI, 0.39 to 14.30; I 2 = 98%). Conclusions: Across the included trial configurations, 12‐month efficacy estimates did not differ detectably. Sparse safety events and wide confidence intervals precluded equivalence claims. Pooled procedure and LA dwell times favored PFA, but platform, comparator, and workflow heterogeneity limit generalizability. Procedural findings are exploratory and should not be interpreted as direct energy‐specific effects.
- 20 August 2026
- Published by Wiley in Journal of Arrhythmia
- Vol. 42 (4) , e70446
Open AccessClinical Outcomes of Pulsed Field Vs. Thermal Ablation for Paroxysmal Atrial Fibrillation: Systematic Review and Meta‐Analysis of Randomized Evidence
Aims: Pulsed field ablation (PFA) is a non‐thermal alternative to conventional thermal ablation for paroxysmal atrial fibrillation (AF). We conducted an updated systematic review and meta‐analysis of randomized evidence comparing efficacy, safety, and procedural outcomes. Methods: PubMed/MEDLINE and the Cochrane Central Register of Controlled Trials were searched from inception through March 2026 for randomized controlled trials (RCTs) comparing PFA with thermal ablation in adults undergoing first catheter ablation for paroxysmal AF. Risk ratios (RRs) or mean differences (MDs) with 95% confidence intervals (CIs) were pooled using random‐effects models. Results: Four RCTs enrolling 1 393 patients were included. PFA showed no statistically detectable difference in 12‐month treatment success (RR, 1.04; 95% CI, 0.97 to 1.12; I 2 = 7%), recurrent atrial arrhythmias (RR, 1.00; 95% CI, 0.77 to 1.29; I 2 = 42%), or composite serious adverse events (RR, 0.71; 95% CI, 0.32 to 1.57; I 2 = 7%). PFA shortened procedure time (MD, −22.42 min; 95% CI, −33.44 to −11.39; I 2 = 91%) and LA dwell time (MD, −25.73 min; 95% CI, −34.66 to −16.79; I 2 = 92%), but increased fluoroscopy time (MD, 7.34 min; 95% CI, 0.39 to 14.30; I 2 = 98%). Conclusions: Across the included trial configurations, 12‐month efficacy estimates did not differ detectably. Sparse safety events and wide confidence intervals precluded equivalence claims. Pooled procedure and LA dwell times favored PFA, but platform, comparator, and workflow heterogeneity limit generalizability. Procedural findings are exploratory and should not be interpreted as direct energy‐specific effects.
- Open Access
- 25 February 2026
- Published by Springer Nature in Thrombosis Journal
- Vol. 24 (1) , 26
Trends and disparities in disseminated intravascular coagulation-related mortality among adults aged 25 and above in the U.S., 1999–2020: CDC WONDER insights
Background: Disseminated intravascular coagulation (DIC) is a severe, life-threatening coagulopathy often secondary to infection, malignancy, or obstetric complications. Despite advances in critical care, national patterns and disparities in DIC-related mortality remain underexplored. Objectives: To examine temporal, demographic, and regional trends in DIC-related mortality among U.S. adults from 1999 to 2020. Methods: Death certificate data were obtained from the CDC WONDER (Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research) database for adults aged ≥ 25 years with DIC listed as an underlying or contributing cause of death. Age-adjusted mortality rates (AAMRs) per 100,000 population and annual percent change (APC) were calculated using Joinpoint regression and stratified by sex, race/ethnicity, age group, urbanization, and region. Results: From 1999 to 2020, 71,241 DIC-related deaths were identified among U.S. adults. The overall AAMR declined from 2.1 per 100,000 in 1999 to 1.6 in 2020. Men had higher mortality than women (1.6 vs. 1.5), and non-Hispanic (NH) Black adults had the highest AAMR (2.8), followed by Hispanic (1.6), and NH White adults (1.4). Mortality was highest among adults ≥ 85 years (6.1), residents of nonmetropolitan areas (1.6), and those in the South (1.6) and Northeast regions (1.5). Conclusions: Following a prolonged decline, DIC-related mortality in U.S. adults has risen since 2017, particularly among men, Black adults, and those in the South and rural areas. Targeted prevention and equitable access to critical care are essential to curb this resurgence.
- 25 February 2026
- Published by Springer Nature in Thrombosis Journal
- Vol. 24 (1) , 26
Open AccessTrends and disparities in disseminated intravascular coagulation-related mortality among adults aged 25 and above in the U.S., 1999–2020: CDC WONDER insights
Background: Disseminated intravascular coagulation (DIC) is a severe, life-threatening coagulopathy often secondary to infection, malignancy, or obstetric complications. Despite advances in critical care, national patterns and disparities in DIC-related mortality remain underexplored. Objectives: To examine temporal, demographic, and regional trends in DIC-related mortality among U.S. adults from 1999 to 2020. Methods: Death certificate data were obtained from the CDC WONDER (Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research) database for adults aged ≥ 25 years with DIC listed as an underlying or contributing cause of death. Age-adjusted mortality rates (AAMRs) per 100,000 population and annual percent change (APC) were calculated using Joinpoint regression and stratified by sex, race/ethnicity, age group, urbanization, and region. Results: From 1999 to 2020, 71,241 DIC-related deaths were identified among U.S. adults. The overall AAMR declined from 2.1 per 100,000 in 1999 to 1.6 in 2020. Men had higher mortality than women (1.6 vs. 1.5), and non-Hispanic (NH) Black adults had the highest AAMR (2.8), followed by Hispanic (1.6), and NH White adults (1.4). Mortality was highest among adults ≥ 85 years (6.1), residents of nonmetropolitan areas (1.6), and those in the South (1.6) and Northeast regions (1.5). Conclusions: Following a prolonged decline, DIC-related mortality in U.S. adults has risen since 2017, particularly among men, Black adults, and those in the South and rural areas. Targeted prevention and equitable access to critical care are essential to curb this resurgence.